To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ACP1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
597 representative clones for gene ACP1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BP873128 embryonal kidney .a 1 to 578 1 to 578 exact tiling clone,   578/582
(99 %)
2 diff
(99.7 %id)
NM_007099.3   .a 1 to 1549 1 to 1549 exact RefSeq, AAA   1549/1549
(100 %)
0 diff
(100 %id)
DA894722 skeletal muscle .a 22 to 563 2 to 543   capped   542/542
(100 %)
2 diff
(99.7 %id)
DA369966 subthalamic nucleus .a 33 to 604 2 to 574 A2L Q106R capped   573/573
(100 %)
3 diff
(99.5 %id)
DA893256 skeletal muscle .a 33 to 527 2 to 496   capped   495/495
(100 %)
1 diff
(99.8 %id)
DA971303 synovial membrane tissue from rheumatioidarthritis .a 33 to 515 2 to 484   capped   483/483
(100 %)
0 diff
(100 %id)
AK289934 hippocampus .a 34 to 871 1 to 838 exact     838/838
(100 %)
0 diff
(100 %id)
DA298017 hippocampus .a 35 to 604 2 to 571 exact capped   570/570
(100 %)
0 diff
(100 %id)
CR609802 Placenta Cot 25-normalized .a 44 to 1530 1 to 1487 exact tiling clone,   1487/1487
(100 %)
0 diff
(100 %id)
AL553386 placenta, Placenta Cot 25-normalized .a 44 to 915 1 to 863 R19X Q106R fully sequenced,   863/863
(100 %)
5 diff
(99.5 %id)
CN344029 embryonic stem cells, DMSO-treated H9 cellline .a 52 to 642 1 to 592 exact     592/592
(100 %)
2 diff
(99.7 %id)
BQ272031 Pancreas, Purified pancreatic islet .a 53 to 646 1 to 594 H67Y G68V     594/594
(100 %)
6 diff
(99.0 %id)
CB178457 Pancreas, Purified pancreatic islet .a 53 to 570 1 to 518       518/518
(100 %)
2 diff
(99.7 %id)
AA375838 lung .a 56 to 240 1 to 184       184/184
(100 %)
4 diff
(97.9 %id)
AA376373 lung .a 56 to 234 1 to 180       180/180
(100 %)
4 diff
(97.8 %id)
CR609595 Placenta Cot 25-normalized .a 58 to 1506 1 to 1449 exact     1449/1449
(100 %)
0 diff
(100 %id)
AL552502 placenta, Placenta Cot 25-normalized .a 58 to 772 1 to 715 exact fully sequenced,   715/715
(100 %)
1 diff
(99.9 %id)
DB479898 hippocampus .a 58 to 560 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
DA008627 adipose .a 59 to 538 2 to 481   capped   480/480
(100 %)
0 diff
(100 %id)
T61405 Liver .a 62 to 496 1 to 447       447/470
(95 %)
20 diff
(95.8 %id)
CR599434 Placenta Cot 25-normalized .a 64 to 1513 1 to 1450 exact     1450/1450
(100 %)
0 diff
(100 %id)
AL549770 placenta, Placenta Cot 25-normalized .a 64 to 950 1 to 871 Q106R fully sequenced,   871/871
(100 %)
3 diff
(99.7 %id)
BI460336 testis .a 65 to 740 1 to 674 exact     674/674
(100 %)
3 diff
(99.6 %id)
DA068091 cerebellum .a 66 to 625 2 to 561 Q106R capped   560/560
(100 %)
2 diff
(99.7 %id)
DA366380 subthalamic nucleus .a 69 to 596 2 to 529 A84T capped   528/528
(100 %)
1 diff
(99.9 %id)
BG704800 brain, hippocampus .a 74 to 730 1 to 653 exact     653/966
(67 %)
12 diff
(98.8 %id)
BG723369 testis .a 74 to 925 1 to 837 F11L V12C C13V L14W G15V ...     837/837
(100 %)
25 diff
(97.1 %id)
CD242437 brain, Pituitary .a 74 to 888 26 to 847 Q106R     822/848
(96 %)
27 diff
(96.9 %id)
BC007422 Muscle, rhabdomyosarcoma .a 75 to 1460 1 to 1386 exact available from MGC, AAA   1386/1386
(100 %)
1 diff
(100.0 %id)
BM704164.
matches multiple genes
eye, Retina Foveal and Macular .a 76 to 574 1 to 498 H158T   also hits gene SLC7A5 498/498
(100 %)
1 diff
(99.8 %id)
BX505193   .a 78 to 657 1 to 579 V47X D82X D130X D136X D138X     579/601
(96 %)
5 diff
(99.2 %id)
BG572828 placenta .a 78 to 753 1 to 678 K103N S104K N105*     678/678
(100 %)
3 diff
(99.6 %id)
CB053859 leiomyosarcoma, soft tissue .a 79 to 389 10 to 320       311/321
(96 %)
10 diff
(96.9 %id)
BM766716 Ascites, stomach .a 81 to 612 1 to 532 exact     532/532
(100 %)
1 diff
(99.9 %id)
AU099935   .a 83 to 382 1 to 300       300/300
(100 %)
6 diff
(98.0 %id)
DB494055 hypothalamus .a 84 to 617 1 to 535 exact     535/539
(99 %)
7 diff
(98.8 %id)
AV705385 adrenal gland .a 85 to 709 1 to 626 exact     626/626
(100 %)
9 diff
(98.6 %id)
BG772194 testis .a 85 to 789 1 to 705 I17V     705/705
(100 %)
6 diff
(99.2 %id)
CN344028 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 86 to 565 1 to 480       480/480
(100 %)
1 diff
(99.8 %id)
CA950936 Pancreas, Purified pancreatic islet .a 87 to 420 1 to 334   fully sequenced,   334/334
(100 %)
2 diff
(99.5 %id)
BX443485 T cells (Jurkat cell line) .a 92 to 903 1 to 807 exact fully sequenced,   807/807
(100 %)
0 diff
(100 %id)
BP419423 small intestine .a 92 to 611 1 to 519 E3D Q4R A5L T6P K7S ...   Submitted on the opposite strand 519/519
(100 %)
3 diff
(99.5 %id)
DR761322 embryonic stem .a 94 to 887 1 to 794 Q106R     794/794
(100 %)
2 diff
(99.8 %id)
AV702145 adrenal gland .a 95 to 835 1 to 721 V47A Q106R     721/722
(99 %)
41 diff
(94.4 %id)
AV701665 adrenal gland .a 95 to 834 1 to 741 E3V Q106R K156N     741/744
(99 %)
18 diff
(97.6 %id)
BE298203 muscle, rhabdomyosarcoma .a 95 to 673 1 to 578 exact     578/578
(100 %)
1 diff
(99.9 %id)
BT007136   .a 97 to 571 1 to 475       475/477
(99 %)
1 diff
(99.8 %id)
CV026633 mixed .a 97 to 572 1 to 476       476/631
(75 %)
1 diff
(99.9 %id)
AI064927 Liver .a 100 to 774 1 to 675   AAA   675/675
(100 %)
8 diff
(98.9 %id)
AI133635 Liver .a 100 to 774 1 to 675   AAA   675/675
(100 %)
2 diff
(99.8 %id)
BQ957142 large cell carcinoma, lung .a 101 to 776 1 to 676   AAA   676/676
(100 %)
2 diff
(99.8 %id)
CV811297 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 101 to 786 27 to 710       684/710
(96 %)
8 diff
(98.9 %id)
TI_149288704   .a 101 to 776 754 to 79   AAA   676/705
(95 %)
3 diff
(99.6 %id)
BM970524 lung .a 101 to 776 692 to 17   AAA   676/684
(98 %)
3 diff
(99.6 %id)
BQ270742 insulinoma, Pancreas .a 103 to 567 1 to 465       465/465
(100 %)
7 diff
(98.5 %id)
M83654   .a 106 to 1549 1 to 1438   tiling clone, AAA   1438/1438
(100 %)
5 diff
(99.7 %id)
M87546 adipose .a 107 to 1549 15 to 1449   AAA   1435/1449
(99 %)
15 diff
(99.0 %id)
S62885   .a 107 to 1549 15 to 1449   AAA   1435/1449
(99 %)
15 diff
(99.0 %id)
BI906317 leukocyte .a 108 to 778 1 to 670       670/679
(98 %)
2 diff
(99.8 %id)
TI_57232211   .a 108 to 778 32 to 701       670/710
(94 %)
8 diff
(98.9 %id)
BG112392 Bone, osteosarcoma, cell line .a 111 to 852 1 to 737       737/947
(77 %)
11 diff
(98.9 %id)
CV336947 placenta_normal .a 114 to 443 330 to 1     Submitted on the opposite strand 330/330
(100 %)
1 diff
(99.7 %id)
AA845429 parathyroid gland, parathyroid tumor .a 114 to 777 671 to 9       663/671
(98 %)
1 diff
(99.9 %id)
BG338752 leiomyosarcoma cell line, uterus .a 116 to 782 1 to 668       669/847
(78 %)
19 diff
(97.8 %id)
BQ324714 colon_ins .a 119 to 450 351 to 23       329/351
(93 %)
3 diff
(99.2 %id)
BQ324738 colon_ins .a 119 to 450 342 to 13       330/342
(96 %)
3 diff
(99.2 %id)
CV336948 placenta_normal .a 119 to 448 1 to 330       330/346
(95 %)
3 diff
(99.2 %id)
CV336956 placenta_normal .a 119 to 443 1 to 325       325/325
(100 %)
0 diff
(100 %id)
CV336963 placenta_normal .a 119 to 453 1 to 335       335/344
(97 %)
5 diff
(98.6 %id)
CV336943 placenta_normal .a 122 to 443 322 to 1     Submitted on the opposite strand 322/322
(100 %)
0 diff
(100 %id)
BQ324711 colon_ins .a 124 to 443 1 to 318       321/318
(100 %)
6 diff
(98.2 %id)
CV336929 placenta_normal .a 127 to 443 317 to 1     Submitted on the opposite strand 317/317
(100 %)
0 diff
(100 %id)
BE872413 adenocarcinoma, colon .a 134 to 839 1 to 702       702/907
(77 %)
20 diff
(97.8 %id)
FN129232 breast carcinoma .a 143 to 233 1 to 90       90/94
(95 %)
2 diff
(97.9 %id)
BF038448 adenocarcinoma, ovary .a 146 to 814 1 to 655       655/773
(84 %)
33 diff
(95.8 %id)
FN079995 breast carcinoma .a 158 to 263 1 to 106       106/107
(99 %)
4 diff
(96.3 %id)
CB045991 2 pooled tumors (clear cell type), Kidney .a 170 to 776 647 to 41   AAA   607/607
(100 %)
2 diff
(99.7 %id)
BQ646724 hepatocellular carcinoma, cell line, Liver .a 198 to 776 2 to 581   AAA   580/581
(99 %)
11 diff
(98.2 %id)
BQ649699 hepatocellular carcinoma, cell line, Liver .a 200 to 776 1 to 577   AAA   577/577
(100 %)
1 diff
(99.9 %id)
BQ643816 hepatocellular carcinoma, cell line, Liver .a 201 to 776 1 to 576   AAA   576/576
(100 %)
2 diff
(99.7 %id)
CA950689 Pancreas, Purified pancreatic islet .a 359 to 778 424 to 5   fully sequenced,   420/424
(99 %)
1 diff
(99.8 %id)
AL575788 placenta, Placenta Cot 25-normalized .a 746 to 1506 762 to 1   fully sequenced,   762/762
(100 %)
2 diff
(99.8 %id)
AL576398 placenta, Placenta Cot 25-normalized .a 885 to 1530 645 to 1   fully sequenced,   645/645
(100 %)
6 diff
(99.1 %id)
AL573837 placenta, Placenta Cot 25-normalized .a 920 to 1503 594 to 10   fully sequenced,   585/594
(98 %)
1 diff
(99.9 %id)
DB330887 skeletal muscle .a 1009 to 1549 542 to 1       542/542
(100 %)
4 diff
(99.3 %id)
BQ271706 Pancreas, Purified pancreatic islet .a 1012 to 1552 541 to 1       541/541
(100 %)
0 diff
(100 %id)
CB178696 Pancreas, Purified pancreatic islet .a 1103 to 1543 455 to 15   AAA   441/441
(100 %)
5 diff
(98.9 %id)
BX443484 T cells (Jurkat cell line) .a 1105 to 1518 418 to 1   fully sequenced,   495/495
(100 %)
32 diff
(93.6 %id)
T61372 Liver .a 1284 to 1539 257 to 1       257/263
(97 %)
3 diff
(98.9 %id)
CB053858 leiomyosarcoma, soft tissue .a 1290 to 1535 277 to 32   AAA   246/246
(100 %)
0 diff
(100 %id)
DB124984 thymus .b 1 to 558 2 to 559   tiling clone, capped   558/558
(100 %)
2 diff
(99.7 %id)
NM_004300.3   .b 505 to 2053 1 to 1549 exact RefSeq, AAA   1549/1549
(100 %)
0 diff
(100 %id)
BI460080 testis .b 507 to 1258 1 to 752 G49R A157G     752/752
(100 %)
10 diff
(98.7 %id)
DB443811 testis .b 526 to 970 1 to 445       445/445
(100 %)
1 diff
(99.8 %id)
CD049230 embryonic stem cells, WA01, passage 38 .b 531 to 1280 10 to 759 V12E Q106R AAA   750/759
(98 %)
10 diff
(98.7 %id)
BG771423 testis .b 531 to 1281 1 to 751 exact     751/751
(100 %)
14 diff
(98.2 %id)
BU601602 mixed (pool of 40 RNAs) .b 533 to 1266 1 to 741 exact     741/793
(93 %)
12 diff
(98.5 %id)
CB154908 brain .b 536 to 1048 1 to 513       513/513
(100 %)
0 diff
(100 %id)
CD385977 embryonic trophoblasts, made from WA01 stemcells .b 536 to 1279 22 to 765 Q106R     744/917
(81 %)
8 diff
(99.2 %id)
DT220459 brain .b 536 to 1210 1 to 675 exact tiling clone,   675/675
(100 %)
0 diff
(100 %id)
DT220933 brain .b 536 to 1153 1 to 618 exact     618/618
(100 %)
0 diff
(100 %id)
BP872697 embryonal kidney .b 536 to 1116 1 to 581 exact     581/581
(100 %)
0 diff
(100 %id)
BP872702 embryonal kidney .b 536 to 1139 1 to 603 G118X     603/603
(100 %)
4 diff
(99.4 %id)
BP872827 embryonal kidney .b 536 to 1116 1 to 582 exact     582/582
(100 %)
1 diff
(99.9 %id)
BP873312 embryonal kidney .b 536 to 1117 1 to 582 exact     582/583
(99 %)
1 diff
(99.9 %id)
CB130427 Liver .b 536 to 1018 1 to 484       484/484
(100 %)
4 diff
(99.2 %id)
BM751548 Ascites, stomach .b 536 to 949 1 to 415       415/415
(100 %)
3 diff
(99.3 %id)
DA000877   .b 537 to 1067 2 to 532   capped   531/531
(100 %)
1 diff
(99.9 %id)
DA214214 brain .b 537 to 1031 2 to 496   capped   495/495
(100 %)
0 diff
(100 %id)
AU128915   .b 537 to 1189 2 to 653 Q106R Y143X A152X A157P H158T capped   652/652
(100 %)
7 diff
(99.0 %id)
CN343124 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 542 to 1224 1 to 683 Q106R     683/683
(100 %)
3 diff
(99.6 %id)
AV751670 Pituitary .b 545 to 1063 1 to 512       512/518
(98 %)
4 diff
(99.3 %id)
DA611763   .b 546 to 1136 2 to 592 exact capped   591/591
(100 %)
0 diff
(100 %id)
M83653   .b 552 to 2053 1 to 1491 exact AAA   1491/1491
(100 %)
9 diff
(99.4 %id)
DA359342 subthalamic nucleus .b 553 to 1108 2 to 557 Q106R capped   556/556
(100 %)
1 diff
(99.9 %id)
BU198429   .b 556 to 1118 1 to 563 Q106R R151I K156N     563/563
(100 %)
8 diff
(98.6 %id)
BX422061 T cells (Jurkat cell line) .b 558 to 1332 1 to 774 exact     774/774
(100 %)
7 diff
(99.1 %id)
BQ277309 mixed (pool of 40 RNAs) .b 558 to 1276 1 to 722 Q106R     722/794
(90 %)
12 diff
(98.5 %id)
BU945635 mixed (pool of 40 RNAs) .b 559 to 1264 1 to 717 exact     717/743
(96 %)
14 diff
(98.2 %id)
CB991300 placenta, pre-eclamptic placenta .b 562 to 1277 28 to 750 Q106R     723/814
(88 %)
17 diff
(98.0 %id)
AA037447 uterus .b 563 to 1033 1 to 478       476/478
(99 %)
10 diff
(98.0 %id)
AL554639 placenta, Placenta Cot 25-normalized .b 564 to 1164 1 to 600 P70S N96X K124N Q125N I127L ...     600/600
(100 %)
6 diff
(99.0 %id)
BE902522 choriocarcinoma, placenta .b 566 to 1356 1 to 766 L10A F11V C18V R19D S20H ...     766/858
(89 %)
30 diff
(96.6 %id)
BM804575 lymph, lymphoma, cell line .b 566 to 1462 1 to 909 K7M V9A     909/1127
(80 %)
40 diff
(96.5 %id)
BG940811 blood .b 569 to 899 1 to 331       331/331
(100 %)
2 diff
(99.4 %id)
BF699686 brain, primitive neuroectoderm .b 569 to 1220 1 to 648 F11L V12C C13V L14W G15V ...     648/864
(75 %)
22 diff
(97.5 %id)
DB468375 hippocampus .b 570 to 999 1 to 430       430/430
(100 %)
1 diff
(99.8 %id)
DN991388 brain, whole brain .b 570 to 1125 1 to 555 Q106R V142A Q144H     555/557
(99 %)
11 diff
(98.1 %id)
DA617130   .b 571 to 1163 2 to 594 exact capped   593/593
(100 %)
0 diff
(100 %id)
BI544974 brain, hippocampus .b 572 to 1178 1 to 607 exact     607/607
(100 %)
2 diff
(99.7 %id)
CD687560 normal nasopharynx .b 574 to 1183 9 to 618 F83L     610/618
(98 %)
9 diff
(98.6 %id)
DB010541 colon, tumor tissue .b 574 to 1100 2 to 528 Q106R capped   527/527
(100 %)
1 diff
(99.9 %id)
BF981402 duodenal adenocarcinoma, cell line, small intestine .b 575 to 1374 1 to 806 Q4E F11L V12C C13V L14W ...     806/808
(99 %)
39 diff
(95.2 %id)
BI666992 brain, hypothalamus .b 575 to 1276 1 to 703 P56H AAA   703/703
(100 %)
8 diff
(98.9 %id)
TI_44000929   .b 575 to 1178 87 to 690 exact     604/690
(87 %)
6 diff
(99.2 %id)
DA617166   .b 576 to 1150 2 to 576 exact capped   575/575
(100 %)
0 diff
(100 %id)
AK291861 skeletal muscle .b 577 to 1494 1 to 918 exact     918/918
(100 %)
0 diff
(100 %id)
BU599908 mixed (pool of 40 RNAs) .b 577 to 1234 1 to 665 Q106R     665/676
(98 %)
11 diff
(98.4 %id)
BU535384 mixed (pool of 40 RNAs) .b 577 to 1282 1 to 711 Y133C     711/761
(93 %)
18 diff
(97.7 %id)
DB477427 hippocampus .b 578 to 1069 1 to 492       492/495
(99 %)
2 diff
(99.6 %id)
DB477464 hippocampus .b 578 to 1073 1 to 498       498/498
(100 %)
4 diff
(99.2 %id)
DA892854 skeletal muscle .b 578 to 1403 2 to 824 exact capped   823/826
(99 %)
9 diff
(99.0 %id)
BF726270 eye, lens .b 579 to 1066 1 to 488       488/488
(100 %)
0 diff
(100 %id)
BU933354 mixed (pool of 40 RNAs) .b 579 to 1271 1 to 697 exact     697/748
(93 %)
8 diff
(99.0 %id)
AB209838 brain .b 580 to 2053 1 to 1474 Q106R tiling clone,   1474/1474
(100 %)
1 diff
(100.0 %id)
AL038969 Kidney .b 580 to 1261 1 to 684 Q106R     684/684
(100 %)
4 diff
(99.5 %id)
AL038970 Kidney .b 580 to 1217 1 to 636 D43E S44Q A45R A46G T47N ...     636/643
(98 %)
7 diff
(99.0 %id)
BU565892 mixed (pool of 40 RNAs) .b 580 to 971 1 to 392       392/423
(92 %)
5 diff
(98.9 %id)
BU861233 mixed (pool of 40 RNAs) .b 580 to 1266 1 to 696 A45S V74F M92R Q106R S119E ...     696/833
(83 %)
37 diff
(95.6 %id)
CX755402 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 580 to 1332 1 to 752 exact   Submitted on the opposite strand 752/752
(100 %)
1 diff
(99.9 %id)
CK023892 brain/CNS, Human Brain - Cerebellar Cortex .b 580 to 1177 1 to 597 exact     597/598
(99 %)
3 diff
(99.5 %id)
TI_44343099   .b 580 to 1276 92 to 789 P56H AAA   698/789
(88 %)
9 diff
(98.9 %id)
BU623892 cell lines, Enchondroma .b 580 to 1280 719 to 19 Q106R AAA   701/711
(98 %)
1 diff
(99.9 %id)
CR624312 Placenta Cot 25-normalized .b 582 to 2038 1 to 1457 exact     1457/1457
(100 %)
0 diff
(100 %id)
AL554577 placenta, Placenta Cot 25-normalized .b 582 to 1283 1 to 700 P70S fully sequenced,   700/700
(100 %)
3 diff
(99.6 %id)
CD251736 brain, Pituitary .b 582 to 1442 1 to 872 exact     872/878
(99 %)
26 diff
(97.1 %id)
BE872974 adenocarcinoma, colon .b 583 to 1353 1 to 757 F11L V12C C13V L14W G15V ...     757/824
(91 %)
29 diff
(96.5 %id)
BI439004 Pancreas, Purified pancreatic islet .b 584 to 1146 1 to 563 exact     563/563
(100 %)
6 diff
(99.0 %id)
CN343111 embryonic stem cells, DMSO-treated H9 cellline .b 584 to 1073 1 to 490       490/490
(100 %)
3 diff
(99.4 %id)
CN343114 embryonic stem cells, cell lines H1, H7, andH9 .b 584 to 1355 1 to 772 Q106R     772/772
(100 %)
6 diff
(99.3 %id)
DN914885   .b 584 to 1184 1 to 599 M71T     599/599
(100 %)
5 diff
(99.2 %id)
BF034433 adenocarcinoma, ovary .b 584 to 1343 1 to 746 Q106R L126V     746/1069
(69 %)
28 diff
(97.4 %id)
BM749997 stomach .b 584 to 1102 1 to 520 A2G E3G Q4Y A5R T6L ...     520/520
(100 %)
6 diff
(98.9 %id)
BM757846 stomach .b 584 to 1098 1 to 513 Y132L Y133W G134E N135*     513/513
(100 %)
2 diff
(99.7 %id)
BF967196 brain, hypothalamus .b 585 to 1215 8 to 636 G134W     629/929
(67 %)
14 diff
(98.5 %id)
CD558454 White Matter .b 586 to 1457 1 to 879 exact     879/879
(100 %)
23 diff
(97.4 %id)
DA753116   .b 586 to 1152 2 to 569 A2V A46G T47N S48F G49R ... capped   568/568
(100 %)
2 diff
(99.7 %id)
CR613475 Placenta Cot 25-normalized .b 588 to 2052 1 to 1465 exact     1465/1465
(100 %)
0 diff
(100 %id)
BX340177 Placenta Cot 25-normalized .b 588 to 1509 1 to 921 L10X F11X L14M S20X R28X ... fully sequenced,   921/921
(100 %)
5 diff
(99.5 %id)
BU603050 mixed (pool of 40 RNAs) .b 588 to 1286 1 to 695 V31K D33A Q34P N35P I36X ...     695/834
(83 %)
28 diff
(96.7 %id)
DA615544   .b 588 to 1125 2 to 542 H158P capped   541/541
(100 %)
4 diff
(99.3 %id)
DR007159 Spleen .b 588 to 1231 1 to 644 E3*     644/644
(100 %)
6 diff
(99.1 %id)
CN343131 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 589 to 1307 1 to 719 Q106R     719/719
(100 %)
3 diff
(99.6 %id)
BM472792 melanotic melanoma, skin .b 589 to 1228 20 to 666 Q106R     647/1075
(60 %)
27 diff
(97.5 %id)
BM561641 duodenal adenocarcinoma, cell line, small intestine .b 589 to 1280 34 to 725 exact AAA   692/725
(95 %)
7 diff
(99.1 %id)
BU187722 eye, retinoblastoma .b 589 to 1468 37 to 916 exact     880/940
(93 %)
18 diff
(98.1 %id)
CN343109 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 590 to 1278 1 to 689 exact AAA   689/689
(100 %)
5 diff
(99.3 %id)
CR591454 neuroblastoma .b 590 to 1585 1 to 996 exact     996/996
(100 %)
0 diff
(100 %id)
AL516132 brain, neuroblastoma, neuroblastoma cells .b 590 to 1484 1 to 895 exact     895/895
(100 %)
0 diff
(100 %id)
BX464426 neuroblastoma .b 590 to 1585 1 to 993 L14M P55R D57*     993/993
(100 %)
15 diff
(98.5 %id)
BI906009 leukocyte .b 590 to 1487 1 to 907 C63L M64H K65E R66E H67A ...     907/1164
(77 %)
41 diff
(96.5 %id)
TI_57231419   .b 590 to 1487 33 to 939 C63L M64H K65E R66E H67A ...     907/1196
(75 %)
47 diff
(96.1 %id)
CR977170 T-Lymphocytes .b 590 to 1269 1 to 680 exact     680/680
(100 %)
1 diff
(99.9 %id)
BI253868 cervical carcinoma cell line, cervix .b 591 to 1485 1 to 885 exact     885/932
(94 %)
36 diff
(96.2 %id)
BG943481 blood .b 592 to 1184 1 to 593 exact     593/593
(100 %)
1 diff
(99.9 %id)
CN343110 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 592 to 890 1 to 299       299/299
(100 %)
0 diff
(100 %id)
CN343129 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 593 to 1291 1 to 699 E38K Q106R     699/699
(100 %)
3 diff
(99.6 %id)
CX755740 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 593 to 1280 1 to 681 exact     681/863
(78 %)
11 diff
(98.8 %id)
BI916379 brain .b 594 to 1181 1 to 585 K7S S8P V9C L10C F11C ...     585/585
(100 %)
6 diff
(99.0 %id)
TI_154120155   .b 594 to 1278 776 to 92 A5X I17X Q106R AAA   685/982
(69 %)
4 diff
(99.6 %id)
F07274 brain, total brain .b 596 to 945 1 to 350       350/350
(100 %)
1 diff
(99.8 %id)
BQ232864 embryonal carcinoma, cell line, testis .b 597 to 1502 1 to 913 E3D Q4R A5L T6P K7V ...     915/932
(98 %)
44 diff
(95.3 %id)
CX755325 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 597 to 1306 1 to 710 exact   Submitted on the opposite strand 710/710
(100 %)
0 diff
(100 %id)
BC106011 Placenta, choriocarcinoma .b 599 to 1278 1 to 680 Q106R AAA   680/680
(100 %)
2 diff
(99.8 %id)
DB126948 thymus .b 599 to 1216 2 to 619 exact capped   618/618
(100 %)
0 diff
(100 %id)
CR597555 Placenta Cot 25-normalized .b 600 to 2021 1 to 1422 exact     1422/1422
(100 %)
0 diff
(100 %id)
CR607431 T cells (Jurkat cell line) .b 600 to 1992 1 to 1393 exact     1393/1393
(100 %)
0 diff
(100 %id)
AL552042 placenta, Placenta Cot 25-normalized .b 600 to 1500 1 to 898 exact fully sequenced,   898/898
(100 %)
0 diff
(100 %id)
BI089129 cervix .b 600 to 1278 1 to 678 L10A F11V C18V R19D S20H ...     678/690
(98 %)
21 diff
(97.0 %id)
BM805287 brain, hippocampus .b 600 to 1280 16 to 695 N16T I17F C18V R19D S20H ...     682/696
(97 %)
3 diff
(99.6 %id)
CN479777 Knee, Osteoarthritic Cartilage .b 600 to 1278 695 to 17 A5X I17X Q106R AAA   679/679
(100 %)
2 diff
(99.8 %id)
CN343119 embryonic stem cells, cell lines H1, H7, andH9 .b 601 to 1106 1 to 506 Q106R     506/506
(100 %)
3 diff
(99.5 %id)
CN343121 embryonic stem cells, DMSO-treated H9 cellline .b 601 to 1344 1 to 744 exact     744/744
(100 %)
0 diff
(100 %id)
AL557406 T cells (Jurkat cell line), T cells from T cell leukemia .b 601 to 1419 1 to 810 Q106R fully sequenced,   810/810
(100 %)
5 diff
(99.4 %id)
BE782654 eye, retinoblastoma .b 601 to 1448 1 to 861 D33E Q34S N35K I36H S37L ...     861/861
(100 %)
47 diff
(94.6 %id)
CN343113 embryonic stem cells, DMSO-treated H9 cellline .b 603 to 1280 9 to 686   AAA   678/686
(98 %)
6 diff
(99.2 %id)
BY798858 eye .b 603 to 1121 1 to 520       520/520
(100 %)
1 diff
(99.9 %id)
BI198942 brain, neuroblastoma .b 603 to 1219 1 to 615       615/891
(69 %)
4 diff
(99.6 %id)
BQ231696 melanotic melanoma, skin .b 603 to 1484 24 to 918       895/919
(97 %)
29 diff
(96.9 %id)
CV573029 cornea, eye .b 603 to 1184 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
F06967 brain, total brain .b 604 to 907 1 to 304       304/304
(100 %)
0 diff
(100 %id)
BG674218 skin .b 604 to 1423 1 to 820       820/1000
(82 %)
11 diff
(98.9 %id)
BI092838 cervix .b 604 to 1334 1 to 721       721/722
(99 %)
19 diff
(97.4 %id)
BM460072 leiomyosarcoma, uterus .b 604 to 1462 1 to 860       860/1068
(80 %)
4 diff
(99.7 %id)
CX165354 human embryonic stem cells differentiated toan early endodermal cell type .b 604 to 1414 8 to 817       810/817
(99 %)
6 diff
(99.3 %id)
CX758215 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 604 to 1380 1 to 771     Submitted on the opposite strand 771/810
(95 %)
13 diff
(98.4 %id)
T09345   .b 605 to 984 1 to 382       382/382
(100 %)
3 diff
(99.3 %id)
CX787633 human embryonic stem cells .b 605 to 1373 1 to 768       768/768
(100 %)
2 diff
(99.8 %id)
CV803646 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 605 to 1334 1 to 721       721/848
(85 %)
13 diff
(98.5 %id)
DR760586 embryonic stem .b 605 to 1373 1 to 768       768/768
(100 %)
2 diff
(99.8 %id)
AA305363 colon .b 606 to 978 1 to 371       371/371
(100 %)
2 diff
(99.5 %id)
AV706268 adrenal gland .b 606 to 1262 1 to 657       657/657
(100 %)
9 diff
(98.7 %id)
CN343122 embryonic stem cells, DMSO-treated H9 cellline .b 607 to 951 1 to 345       345/345
(100 %)
3 diff
(99.2 %id)
BQ072782 leukocyte .b 607 to 1529 1 to 934       934/1039
(89 %)
27 diff
(97.5 %id)
AA775756 whole brain .b 610 to 1279 671 to 4       668/671
(99 %)
3 diff
(99.6 %id)
CR991357 T-Lymphocytes .b 610 to 1273 1 to 664       664/664
(100 %)
0 diff
(100 %id)
CD580063 brain .b 611 to 1349 1 to 733       733/735
(99 %)
45 diff
(93.9 %id)
BQ920860 carcinoma, cell line, Prostate .b 612 to 1425 1 to 828       828/915
(90 %)
28 diff
(97.0 %id)
BU186543 eye, retinoblastoma .b 614 to 1456 1 to 852       852/861
(98 %)
11 diff
(98.8 %id)
BQ883391 ductal carcinoma, cell line, Pancreas .b 614 to 1278 1 to 665   AAA   665/665
(100 %)
3 diff
(99.6 %id)
R15414 whole brain .b 616 to 992 1 to 382       382/382
(100 %)
13 diff
(96.6 %id)
BI087054 cervix .b 616 to 1291 1 to 671       671/672
(99 %)
9 diff
(98.7 %id)
CV336951 placenta_normal .b 618 to 947 330 to 1     Submitted on the opposite strand 330/330
(100 %)
3 diff
(99.1 %id)
BF033844 adenocarcinoma, ovary .b 618 to 1384 1 to 762       762/845
(90 %)
29 diff
(96.6 %id)
BU539875 adenocarcinoma, cell line, breast .b 618 to 1279 1 to 662       662/689
(96 %)
2 diff
(99.8 %id)
CB162252 Liver .b 618 to 1212 1 to 595       595/595
(100 %)
0 diff
(100 %id)
CB162319 Liver .b 618 to 1160 1 to 543       543/543
(100 %)
0 diff
(100 %id)
CV336930 placenta_normal .b 620 to 947 328 to 1     Submitted on the opposite strand 328/328
(100 %)
3 diff
(99.1 %id)
CN343116 embryonic stem cells, DMSO-treated H9 cellline .b 621 to 1141 1 to 522       522/522
(100 %)
1 diff
(99.9 %id)
CN343118 embryonic stem cells, cell lines H1, H7, andH9 .b 621 to 1275 1 to 654       654/654
(100 %)
1 diff
(99.9 %id)
CN343127 embryonic stem cells, cell lines H1, H7, andH9 .b 622 to 1124 1 to 502       502/502
(100 %)
4 diff
(99.3 %id)
CV336972 placenta_normal .b 623 to 943 1 to 321       321/321
(100 %)
5 diff
(98.5 %id)
BU169685 large cell carcinoma, lung .b 623 to 1282 1 to 660   AAA   660/660
(100 %)
1 diff
(99.9 %id)
CF145464 CNCAP(3)T-225 cell line, Prostate .b 624 to 1359 8 to 744       737/744
(99 %)
9 diff
(98.8 %id)
TI_154177174   .b 624 to 1166 81 to 623       543/544
(99 %)
5 diff
(99.1 %id)
TI_154177688   .b 624 to 1459 76 to 911       836/836
(100 %)
10 diff
(98.9 %id)
BE618323 eye, retinoblastoma .b 625 to 1383 1 to 760       760/922
(82 %)
17 diff
(98.2 %id)
CN343130 embryonic stem cells, DMSO-treated H9 cellline .b 627 to 1018 1 to 392       392/392
(100 %)
0 diff
(100 %id)
CV336952 placenta_normal .b 627 to 947 321 to 1     Submitted on the opposite strand 321/321
(100 %)
0 diff
(100 %id)
BE780538 eye, retinoblastoma .b 631 to 1403 1 to 765       765/922
(82 %)
24 diff
(97.4 %id)
AI889820 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 643 to 1280 636 to 1       636/645
(98 %)
14 diff
(97.9 %id)
BE536770 cervix .b 643 to 1340 20 to 720       701/821
(85 %)
39 diff
(95.3 %id)
BI258161 cervical carcinoma cell line, cervix .b 643 to 1496 18 to 861       844/997
(84 %)
44 diff
(95.6 %id)
CF145029 CNCAP(3)T-225 cell line, Prostate .b 643 to 1099 27 to 483       457/483
(94 %)
7 diff
(98.6 %id)
DR763668 embryonic stem .b 648 to 1390 1 to 743       743/743
(100 %)
0 diff
(100 %id)
BQ324712 colon_ins .b 652 to 947 296 to 1       296/296
(100 %)
1 diff
(99.7 %id)
CB105331 Liver .b 652 to 1247 1 to 596       596/596
(100 %)
0 diff
(100 %id)
AW439519 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 658 to 1280 623 to 1       623/623
(100 %)
3 diff
(99.6 %id)
M87545 adipose .b 660 to 1595 31 to 963       933/970
(96 %)
16 diff
(98.4 %id)
S62884   .b 660 to 1595 31 to 963       933/970
(96 %)
16 diff
(98.4 %id)
H67599 liver and spleen .b 666 to 1023 1 to 362       362/362
(100 %)
7 diff
(98.1 %id)
TI_154187596   .b 667 to 1355 121 to 805       685/934
(73 %)
18 diff
(98.1 %id)
TI_154188182   .b 667 to 1592 118 to 1042       925/942
(98 %)
33 diff
(96.5 %id)
TI_154188210   .b 667 to 1345 124 to 801       678/916
(74 %)
25 diff
(97.3 %id)
AA479138 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 673 to 1102 1 to 430   fully sequenced,   430/430
(100 %)
4 diff
(99.1 %id)
BE081837 breast .b 684 to 891 1 to 209       209/209
(100 %)
3 diff
(98.6 %id)
AV754012 pituitary tumor .b 687 to 1023 1 to 330       330/330
(100 %)
5 diff
(98.5 %id)
T27875 eye .b 710 to 1104 1 to 400       400/400
(100 %)
5 diff
(98.8 %id)
BQ226796 embryonal carcinoma, cell line, testis .b 711 to 1278 1 to 568   AAA   568/568
(100 %)
0 diff
(100 %id)
BF375127 stomach .b 721 to 1174 454 to 1       454/454
(100 %)
7 diff
(98.5 %id)
FN118362 breast carcinoma .b 744 to 804 62 to 1     Submitted on the opposite strand 62/63
(98 %)
1 diff
(98.5 %id)
BI260734 cervical carcinoma cell line, cervix .b 758 to 1559 1 to 804       804/806
(99 %)
9 diff
(98.9 %id)
CN343120 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 766 to 1328 1 to 564       564/564
(100 %)
6 diff
(99.0 %id)
R29518   .b 774 to 967 1 to 194       194/194
(100 %)
0 diff
(100 %id)
BM667352 eye, fetal eyes .b 792 to 1282 507 to 17   AAA   491/491
(100 %)
0 diff
(100 %id)
AA604448 breast .b 800 to 1081 282 to 1     Submitted on the opposite strand 282/282
(100 %)
1 diff
(99.7 %id)
DB567091 hypothalamus .b 806 to 1274 1 to 469     Submitted on the opposite strand 469/471
(99 %)
1 diff
(99.8 %id)
BE905801 epithelioid carcinoma, Pancreas .b 820 to 1280 1 to 461       461/461
(100 %)
0 diff
(100 %id)
BM853921 stomach .b 824 to 1281 1 to 458       458/464
(98 %)
2 diff
(99.6 %id)
AA479139 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1072 to 1281 209 to 1   fully sequenced,   209/209
(100 %)
1 diff
(99.6 %id)
AL577225 placenta, Placenta Cot 25-normalized .b 1253 to 2038 785 to 1   fully sequenced,   785/785
(100 %)
25 diff
(96.9 %id)
AL554697 placenta, Placenta Cot 25-normalized .b 1363 to 2012 662 to 9       654/662
(98 %)
0 diff
(100 %id)
AL579450 T cells (Jurkat cell line), T cells from T cell leukemia .b 1389 to 1993 600 to 1   fully sequenced,   600/600
(100 %)
26 diff
(95.7 %id)
AL575565 placenta, Placenta Cot 25-normalized .b 1470 to 2021 554 to 1   fully sequenced,   554/554
(100 %)
4 diff
(99.3 %id)
BX330717 Placenta Cot 25-normalized .b 1479 to 2052 576 to 1   fully sequenced,   576/576
(100 %)
20 diff
(96.6 %id)
AU151133   .b 1490 to 2047 566 to 1       566/570
(99 %)
17 diff
(97.1 %id)
DB330779 skeletal muscle .b 1583 to 2053 474 to 1       474/476
(99 %)
8 diff
(98.4 %id)
R16156 whole brain .b 1605 to 2053 472 to 14   AAA   459/459
(100 %)
12 diff
(97.4 %id)
AA037448 uterus .b 1608 to 2053 448 to 1       448/448
(100 %)
3 diff
(99.4 %id)
F03241 brain, total brain .b 1753 to 2053 301 to 1       301/301
(100 %)
0 diff
(100 %id)
F03547 brain, total brain .b 1787 to 2053 267 to 1       267/267
(100 %)
0 diff
(100 %id)
NM_001040649.2   .c 1 to 658 1 to 658 exact RefSeq,   658/658
(100 %)
0 diff
(100 %id)
DA378283 thalamus .c 33 to 583 2 to 552 exact tiling clone, capped   551/551
(100 %)
0 diff
(100 %id)
DA168390 amygdala .c 67 to 635 2 to 570 exact capped   569/569
(100 %)
0 diff
(100 %id)
DB111902 thymus .c 67 to 637 2 to 572 K65R tiling clone, capped   571/571
(100 %)
1 diff
(99.9 %id)
BP363227 lung .c 71 to 657 1 to 587 A2P tiling clone,   587/587
(100 %)
4 diff
(99.4 %id)
BX480534   .c 81 to 734 1 to 653 K7S S8P V9C L10C F11L ... tiling clone,   653/653
(100 %)
7 diff
(99.0 %id)
CB270223 adipose .c 100 to 515 1 to 416       416/416
(100 %)
1 diff
(99.8 %id)
AI056981 liver and spleen .d 1 to 731 730 to 0 K7S S8P V9C L10C F11L ... tiling clone,   730/730
(100 %)
3 diff
(99.6 %id)
W01849 lung .d 412 to 750 1 to 347   tiling clone,   347/353
(98 %)
9 diff
(97.5 %id)
N75342 lung .d 1928 to 2201 276 to 1   tiling clone,   276/283
(97 %)
3 diff
(99.0 %id)
DA469183   .e 1 to 574 2 to 575 Q43R tiling clone, capped   574/574
(100 %)
2 diff
(99.7 %id)
DA937881 Spleen .f 1 to 576 7 to 581 K64N F65S H66M V67F S68L ... tiling clone, capped   580/580
(100 %)
1 diff
(99.9 %id)
BI519994 brain, medulla .g 1 to 689 1 to 692 exact tiling clone, fully sequenced,   692/692
(100 %)
9 diff
(98.7 %id)
TI_43964035   .g 1 to 689 69 to 760 exact fully sequenced,   692/760
(91 %)
14 diff
(98.2 %id)
CB961742 placenta, pre-eclamptic placenta .g 47 to 690 28 to 671 exact tiling clone, AAA   644/671
(95 %)
7 diff
(99.0 %id)
DW430267 Liver .g 52 to 426 15 to 389 W40R     375/389
(96 %)
11 diff
(97.2 %id)
DW433279 Liver .g 145 to 392 16 to 263       248/263
(94 %)
8 diff
(97.0 %id)
BI520797 brain, medulla .g 273 to 623 367 to 15   tiling clone, fully sequenced,   353/367
(96 %)
1 diff
(99.8 %id)
TI_43964036   .g 273 to 623 367 to 15   fully sequenced,   353/367
(96 %)
1 diff
(99.8 %id)
BG547196 lung .h 1 to 711 2 to 713 exact available from MGC,   713/715
(99 %)
9 diff
(98.8 %id)
BC020699 lung .h 1 to 1141 1 to 1141 exact tiling clone, available from MGC, AAA   1141/1141
(100 %)
1 diff
(100.0 %id)
DA176766 amygdala .h 25 to 576 2 to 554 A46G T47N S48F G49R G50W ... capped   553/553
(100 %)
2 diff
(99.7 %id)
CN289609 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 290 to 894 1 to 605       605/605
(100 %)
2 diff
(99.7 %id)
DB136127 thymus .i 1 to 537 2 to 539 G45R A46C V47C S48F D49* tiling clone, capped   538/538
(100 %)
2 diff
(99.7 %id)
DA244450 brain .i 19 to 604 2 to 587 exact tiling clone, capped   586/586
(100 %)
0 diff
(100 %id)
AA429179 ovarian tumor, ovary .i 416 to 860 1 to 445   tiling clone,   445/445
(100 %)
3 diff
(99.4 %id)
R95828 liver and spleen .i 985 to 1452 1 to 472   tiling clone,   472/479
(98 %)
10 diff
(98.0 %id)
AA249366   .i 1456 to 1818 1 to 362   tiling clone,   362/362
(100 %)
9 diff
(97.6 %id)
AA768207 germinal center B cell .i 1583 to 1978 399 to 3   tiling clone,   397/399
(99 %)
0 diff
(100 %id)
AA897765 pooled .i 1602 to 1971 370 to 1       370/370
(100 %)
0 diff
(100 %id)
AI191472 lung .i 1666 to 2138 473 to 1       473/473
(100 %)
0 diff
(100 %id)
AA428982 ovarian tumor, ovary .i 1739 to 2140 402 to 1   tiling clone,   402/402
(100 %)
0 diff
(100 %id)
H08291 whole brain .i 1962 to 2501 1 to 546   tiling clone,   546/547
(99 %)
20 diff
(96.4 %id)
DA811796 ovary, tumor tissue .i 2547 to 3341 2 to 793   tiling clone, capped   793/794
(99 %)
12 diff
(98.5 %id)
BE765659 nervous_tumor .i 2776 to 3226 451 to 1       451/451
(100 %)
1 diff
(99.8 %id)
AW305254 pooled .i 3029 to 3560 531 to 1   tiling clone,   531/535
(99 %)
4 diff
(99.3 %id)
AA056687 uterus .i 3552 to 4135 1 to 596   tiling clone, fully sequenced,   596/596
(100 %)
20 diff
(96.7 %id)
CN343115 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 3565 to 4215 1 to 651       651/651
(100 %)
3 diff
(99.6 %id)
AI521656 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .i 3569 to 4334 762 to 1       762/816
(93 %)
36 diff
(95.6 %id)
BG107950 Bone, osteosarcoma, cell line .i 3572 to 4156 1 to 592       592/592
(100 %)
9 diff
(98.5 %id)
R75941 placenta .i 3579 to 3982 1 to 411       411/417
(98 %)
20 diff
(95.3 %id)
R75971 placenta .i 3579 to 3982 1 to 417       417/426
(97 %)
28 diff
(93.5 %id)
CK004090 brain/CNS, Human Brain - Cerebellar Cortex .i 3587 to 4197 1 to 611       611/611
(100 %)
8 diff
(98.7 %id)
R01838 liver and spleen .i 3593 to 3978 1 to 403       403/405
(99 %)
31 diff
(92.4 %id)
CD357647 Blood vessels - aorta, basilar and artery .i 3593 to 4319 1 to 743       743/747
(99 %)
27 diff
(96.4 %id)
BM825165 Ascites, stomach .i 3594 to 4114 1 to 521       521/521
(100 %)
0 diff
(100 %id)
AA026979 uterus .i 3603 to 3795 6 to 198       193/198
(97 %)
6 diff
(97.0 %id)
AA838820 parathyroid gland, parathyroid tumor .i 3604 to 4308 701 to 3       699/735
(95 %)
0 diff
(100 %id)
BE937279 stomach .i 3612 to 3888 281 to 5       277/285
(97 %)
0 diff
(100 %id)
W45098 senescent fibroblast .i 3620 to 4020 1 to 407   fully sequenced,   407/407
(100 %)
11 diff
(97.3 %id)
BM765786 stomach .i 3621 to 3908 1 to 288       288/288
(100 %)
4 diff
(98.7 %id)
BU684611 lung, Primary Lung Cystic Fibrosis EpithelialCells .i 3634 to 4320 699 to 13   AAA   687/687
(100 %)
0 diff
(100 %id)
BU618076 Bone, Subchondral Bone .i 3636 to 4334 717 to 19   AAA   699/699
(100 %)
1 diff
(99.9 %id)
BE928272 colon .i 3649 to 4225 578 to 3       576/579
(99 %)
0 diff
(100 %id)
BE842899 stomach .i 3650 to 3881 1 to 232       232/232
(100 %)
4 diff
(98.3 %id)
BX373737 Placenta Cot 25-normalized .i 3655 to 4330 704 to 30       675/891
(75 %)
0 diff
(100 %id)
CV570727 cornea, eye .i 3657 to 3837 1 to 181       181/181
(100 %)
4 diff
(97.8 %id)
BQ021638 lung, Metastatic Chondrosarcoma .i 3660 to 4328 684 to 17   AAA   668/675
(98 %)
1 diff
(99.9 %id)
AI218198 pooled .i 3661 to 4246 576 to 1       576/576
(100 %)
14 diff
(97.6 %id)
BM980953 lung, Primary Lung Cystic Fibrosis EpithelialCells .i 3664 to 4334 687 to 17   AAA   671/671
(100 %)
0 diff
(100 %id)
BM716010 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .i 3664 to 4004 1 to 341   fully sequenced,   341/341
(100 %)
0 diff
(100 %id)
CA429977 Cell Line, Chondrosarcoma .i 3664 to 4334 687 to 17   AAA   671/671
(100 %)
1 diff
(99.9 %id)
CA307824 Alveolar Macrophage, lung .i 3664 to 4334 689 to 19   AAA   671/671
(100 %)
1 diff
(99.9 %id)
AA133970 uterus .i 3666 to 3740 1 to 76       76/93
(81 %)
2 diff
(97.9 %id)
CN480873 Aveolar Macrophage, lung .i 3673 to 4334 677 to 17   AAA   661/661
(100 %)
1 diff
(99.9 %id)
BX361354 Placenta Cot 25-normalized .i 3675 to 4329 1 to 654       654/662
(98 %)
7 diff
(99.0 %id)
AA233769.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 3675 to 4151 474 to 1     also hits gene PIGM 474/530
(89 %)
7 diff
(98.7 %id)
N83728   .i 3675 to 3915 1 to 234       234/236
(99 %)
12 diff
(95.0 %id)
AA639103 Ewing's sarcoma .i 3679 to 4149 472 to 1       472/472
(100 %)
7 diff
(98.6 %id)
W38947 parathyroid gland, parathyroid tumor .i 3680 to 4207 1 to 526   fully sequenced,   526/526
(100 %)
10 diff
(98.1 %id)
R87795 liver and spleen .i 3699 to 4156 1 to 464   fully sequenced,   464/464
(100 %)
12 diff
(97.5 %id)
BU581600 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .i 3704 to 4295 1 to 592       592/592
(100 %)
0 diff
(100 %id)
CN479198 lung, Primary Lung Cystic Fibrosis EpithelialCells .i 3707 to 4314 625 to 17   AAA   609/609
(100 %)
2 diff
(99.7 %id)
BX481618   .i 3709 to 4337 645 to 17   tiling clone, Submitted on the opposite strand 629/645
(97 %)
0 diff
(100 %id)
DN914884   .i 3713 to 4334 619 to 2       618/619
(99 %)
0 diff
(100 %id)
AI924808 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .i 3724 to 4334 605 to 1       605/605
(100 %)
11 diff
(98.2 %id)
AA130248 uterus .i 3727 to 4329 596 to 9       588/599
(98 %)
0 diff
(100 %id)
BM547901 brain, hippocampus .i 3737 to 4335 9 to 607       599/611
(98 %)
5 diff
(99.2 %id)
BQ027214 lung, Metastatic Chondrosarcoma .i 3738 to 4322 603 to 19   AAA   585/585
(100 %)
1 diff
(99.9 %id)
AA481158 germinal center B cell .i 3748 to 4322 585 to 12   AAA   574/574
(100 %)
1 diff
(99.9 %id)
BI759078 pooled colon, kidney, stomach .i 3748 to 4334 1 to 587   AAA   587/587
(100 %)
1 diff
(99.9 %id)
TI_57146221   .i 3748 to 4334 61 to 647   AAA   587/647
(90 %)
6 diff
(99.1 %id)
BP385353 pancreatic islet .i 3749 to 4337 1 to 591     Submitted on the opposite strand 591/593
(99 %)
3 diff
(99.5 %id)
AA604643 adrenal adenoma, adrenal gland .i 3756 to 4324 565 to 6       560/575
(97 %)
0 diff
(100 %id)
AU154812 ovary, tumor tissue .i 3763 to 4335 575 to 2       574/608
(94 %)
0 diff
(100 %id)
AI984017 adenocarcinoma, Pancreas .i 3767 to 4330 564 to 1       564/564
(100 %)
2 diff
(99.7 %id)
AW028797 fibrotheoma, ovary .i 3767 to 4333 569 to 3       567/569
(99 %)
0 diff
(100 %id)
AW338058 adenocarcinoma, Pancreas .i 3767 to 4337 572 to 2       571/572
(99 %)
0 diff
(100 %id)
BE675429 B-cell, chronic lymphotic leukemia .i 3767 to 4337 572 to 2       571/572
(99 %)
0 diff
(100 %id)
AA614612 breast .i 3768 to 4333 564 to 1       564/565
(99 %)
8 diff
(98.6 %id)
AI829250 normal prostate, Prostate .i 3768 to 4196 427 to 1       427/427
(100 %)
31 diff
(92.8 %id)
AW262609 brain, three pooled meningiomas .i 3768 to 4334 568 to 1       568/568
(100 %)
4 diff
(99.3 %id)
AI419018 brain, glioblastoma (pooled) .i 3770 to 4330 561 to 1       561/561
(100 %)
4 diff
(99.3 %id)
AW769370 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .i 3773 to 4334 562 to 1       562/562
(100 %)
0 diff
(100 %id)
AI660127 thymus, pooled .i 3778 to 4337 559 to 1       559/559
(100 %)
15 diff
(97.4 %id)
AW771093 colon, juvenile granulosa tumor .i 3779 to 4335 557 to 1       557/557
(100 %)
1 diff
(99.9 %id)
AA594650 colon, colon tumor RER+ .i 3784 to 4333 546 to 1       546/566
(96 %)
27 diff
(95.3 %id)
AI193462 lung .i 3789 to 4334 547 to 1       547/567
(96 %)
36 diff
(93.7 %id)
BI438677 Pancreas, Purified pancreatic islet .i 3791 to 4337 548 to 2       547/548
(99 %)
0 diff
(100 %id)
BM310512 Pancreas, Purified pancreatic islet .i 3791 to 4331 541 to 1       541/541
(100 %)
0 diff
(100 %id)
BU581273 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .i 3791 to 4336 546 to 1       546/546
(100 %)
0 diff
(100 %id)
EC459235 Prostate .i 3793 to 3897 11 to 115       105/115
(91 %)
6 diff
(94.8 %id)
AI673472 colon, colonic mucosa from 5 ulcerative colitispatients .i 3794 to 4315 522 to 1       522/522
(100 %)
5 diff
(99.1 %id)
BU631081 cell lines, Chondrosarcoma .i 3797 to 4334 556 to 19   AAA   538/538
(100 %)
2 diff
(99.7 %id)
BX119875 whole brain .i 3798 to 4334 553 to 15   AAA   539/539
(100 %)
2 diff
(99.7 %id)
EL949648 eyeball .i 3799 to 4334 30 to 565   AAA   536/565
(94 %)
6 diff
(99.0 %id)
BM997235 lung, Metastatic Chondrosarcoma .i 3802 to 4320 530 to 13   AAA   518/518
(100 %)
1 diff
(99.9 %id)
AA722388 heart .i 3824 to 4337 512 to 1       512/512
(100 %)
13 diff
(97.5 %id)
AA995937 Kidney .i 3834 to 4333 501 to 1       501/501
(100 %)
0 diff
(100 %id)
AI356490 B-cell, chronic lymphotic leukemia .i 3834 to 4335 505 to 1       505/505
(100 %)
3 diff
(99.5 %id)
AA724179 parathyroid gland, parathyroid tumor .i 3837 to 4310 473 to 1       473/473
(100 %)
12 diff
(97.5 %id)
BP384209 pancreatic islet .i 3842 to 4337 1 to 498     Submitted on the opposite strand 498/500
(99 %)
3 diff
(99.4 %id)
AI338070 lung .i 3843 to 4335 492 to 1       492/492
(100 %)
5 diff
(99.0 %id)
AI948412 anaplastic oligodendroglioma, brain .i 3843 to 4335 493 to 1       493/493
(100 %)
1 diff
(99.8 %id)
BQ030197 lung, Metastatic Chondrosarcoma .i 3846 to 4322 495 to 19   AAA   477/477
(100 %)
1 diff
(99.8 %id)
AI141163 lung .i 3850 to 4337 491 to 4       488/491
(99 %)
0 diff
(100 %id)
AI580441 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .i 3851 to 4337 482 to 1       482/482
(100 %)
14 diff
(97.1 %id)
AI022891 parathyroid gland, parathyroid tumor .i 3852 to 4337 489 to 4       486/489
(99 %)
0 diff
(100 %id)
H50391 brain .i 3853 to 4269 1 to 425   fully sequenced,   425/425
(100 %)
21 diff
(95.1 %id)
AI141086 lung .i 3854 to 4334 499 to 19   AAA   481/481
(100 %)
0 diff
(100 %id)
AI948538 anaplastic oligodendroglioma, brain .i 3854 to 4337 490 to 7       484/490
(98 %)
0 diff
(100 %id)
AA568474 colon, colon tumor RER+ .i 3857 to 4337 482 to 2       481/482
(99 %)
0 diff
(100 %id)
AW023434 cochlea, ear .i 3858 to 4334 8 to 484   AAA   477/484
(98 %)
6 diff
(98.8 %id)
AW241358 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .i 3860 to 4337 479 to 3       477/483
(98 %)
0 diff
(100 %id)
AI445172 colon, moderately-differentiated adenocarcinoma .i 3863 to 4328 466 to 1       466/466
(100 %)
4 diff
(99.2 %id)
DB565087 hypothalamus .i 3867 to 4320 1 to 454     Submitted on the opposite strand 454/454
(100 %)
1 diff
(99.8 %id)
AI167646 pooled .i 3867 to 4334 483 to 16   AAA   468/468
(100 %)
1 diff
(99.8 %id)
BF803681 colon_ins .i 3868 to 4224 1 to 357       357/357
(100 %)
8 diff
(97.8 %id)
N45112 multiple sclerosis lesions .i 3868 to 4334 474 to 1       474/486
(97 %)
16 diff
(96.8 %id)
DB548631 hippocampus .i 3870 to 4322 1 to 453     Submitted on the opposite strand 453/453
(100 %)
0 diff
(100 %id)
AW079168 colon, juvenile granulosa tumor .i 3870 to 4320 450 to 1       450/464
(96 %)
13 diff
(97.2 %id)
BF593627 brain, glioblastoma (pooled) .i 3876 to 4332 457 to 1       457/457
(100 %)
2 diff
(99.6 %id)
AA939309 Kidney .i 3877 to 4326 450 to 1       450/450
(100 %)
12 diff
(97.4 %id)
BG056336 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .i 3877 to 4337 470 to 6       465/470
(98 %)
0 diff
(100 %id)
BF939491 brain, glioblastoma (pooled) .i 3878 to 4330 453 to 1       453/453
(100 %)
1 diff
(99.8 %id)
AA939307 Kidney .i 3879 to 4324 446 to 1       446/446
(100 %)
13 diff
(97.1 %id)
AI167367 senescent fibroblast .i 3879 to 4337 461 to 3       459/461
(99 %)
0 diff
(100 %id)
DB508782 testis .i 3880 to 4319 1 to 442     Submitted on the opposite strand 442/443
(99 %)
28 diff
(93.7 %id)
AI351458   .i 3886 to 4292 403 to 1       403/411
(98 %)
13 diff
(96.9 %id)
AA973165 pooled germ cell tumors .i 3888 to 4331 452 to 3       450/452
(99 %)
0 diff
(100 %id)
AI168086 senescent fibroblast .i 3890 to 4337 454 to 7       448/454
(98 %)
0 diff
(100 %id)
DB546070 hippocampus .i 3893 to 4330 1 to 438     Submitted on the opposite strand 438/438
(100 %)
0 diff
(100 %id)
AA775562 heart .i 3894 to 4335 435 to 1       435/438
(99 %)
6 diff
(98.7 %id)
AW664790 pooled .i 3896 to 4337 446 to 6       441/449
(98 %)
0 diff
(100 %id)
DB535631 hippocampus .i 3898 to 4335 1 to 439     Submitted on the opposite strand 439/440
(99 %)
6 diff
(98.7 %id)
BI256825 cervical carcinoma cell line, cervix .i 3908 to 4321 1 to 414   AAA   414/414
(100 %)
4 diff
(99.1 %id)
AA693391 parathyroid gland, parathyroid tumor .i 3909 to 4324 419 to 5       415/419
(99 %)
0 diff
(100 %id)
AW975175   .i 3909 to 4334 111 to 536   AAA   426/536
(79 %)
12 diff
(97.8 %id)
BG056276 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .i 3911 to 4337 432 to 6       427/432
(98 %)
0 diff
(100 %id)
AA657559 alveolar rhabdomyosarcoma .i 3912 to 4320 1 to 410       410/410
(100 %)
5 diff
(98.8 %id)
AA844173 parathyroid gland, parathyroid tumor .i 3920 to 4334 431 to 17   AAA   415/493
(84 %)
1 diff
(99.8 %id)
AA130244 uterus .i 3922 to 4329 415 to 9       407/484
(84 %)
0 diff
(100 %id)
FN098105 breast carcinoma .i 3926 to 3981 1 to 56       56/57
(98 %)
1 diff
(98.3 %id)
AA918042 Kidney .i 3928 to 4328 432 to 25   AAA   408/419
(97 %)
17 diff
(96.0 %id)
AA729348 alveolar rhabdomyosarcoma .i 3930 to 4336 411 to 1       411/411
(100 %)
6 diff
(98.6 %id)
AA746904 alveolar rhabdomyosarcoma .i 3930 to 4336 408 to 1       408/408
(100 %)
28 diff
(93.2 %id)
BI044648 ovary .i 3939 to 4150 218 to 6       213/218
(97 %)
0 diff
(100 %id)
BE328756 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .i 3945 to 4469 523 to 1   tiling clone,   523/523
(100 %)
13 diff
(97.6 %id)
AA954280 pooled .i 3951 to 4335 385 to 1       385/385
(100 %)
1 diff
(99.8 %id)
DB530858 hippocampus .i 3962 to 4334 1 to 375     Submitted on the opposite strand 375/375
(100 %)
18 diff
(95.2 %id)
CK825260 Pancreas, Purified pancreatic islet .i 3967 to 4337 373 to 3     Submitted on the opposite strand 371/373
(99 %)
0 diff
(100 %id)
BU739758 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .i 3974 to 4335 380 to 19   fully sequenced, AAA   362/362
(100 %)
2 diff
(99.5 %id)
AA883589 pooled .i 3981 to 4327 346 to 1       346/363
(95 %)
19 diff
(94.8 %id)
AA494129 colon .i 3983 to 4337 355 to 1       355/355
(100 %)
1 diff
(99.8 %id)
T23790   .i 3990 to 4337 349 to 1       349/349
(100 %)
2 diff
(99.5 %id)
W45148 senescent fibroblast .i 3990 to 4339 360 to 1   fully sequenced,   360/360
(100 %)
11 diff
(97.0 %id)
BF107175 placenta .i 3995 to 4308 1 to 312       312/640
(48 %)
12 diff
(98.2 %id)
AI672061 Kidney .i 3999 to 4334 336 to 1       336/336
(100 %)
1 diff
(99.8 %id)
H08193 whole brain .i 4003 to 4337 349 to 6       344/392
(87 %)
0 diff
(100 %id)
R00222 liver and spleen .i 4003 to 4336 348 to 1       348/398
(87 %)
17 diff
(95.8 %id)
BU588100 mixed (pool of 40 RNAs) .i 4008 to 4322 1 to 315   AAA   315/315
(100 %)
2 diff
(99.4 %id)
AA659676 alveolar rhabdomyosarcoma .i 4011 to 4328 1 to 316       316/316
(100 %)
17 diff
(94.7 %id)
T27689 uterus .i 4039 to 4330 1 to 292       292/296
(98 %)
1 diff
(99.7 %id)
AW951882   .i 4040 to 4334 1 to 295   AAA   295/295
(100 %)
0 diff
(100 %id)
H50354 brain .i 4060 to 4296 247 to 1   fully sequenced,   247/247
(100 %)
4 diff
(98.4 %id)
D57052   .i 4094 to 4334 1 to 241       241/241
(100 %)
1 diff
(99.6 %id)
D57072   .i 4094 to 4334 1 to 241       241/241
(100 %)
1 diff
(99.6 %id)
D57657   .i 4104 to 4334 1 to 229       229/229
(100 %)
2 diff
(99.2 %id)
AA056583 uterus .i 4105 to 4334 230 to 1   fully sequenced,   230/230
(100 %)
9 diff
(96.1 %id)
D58259   .i 4115 to 4334 1 to 217       217/217
(100 %)
3 diff
(98.7 %id)
R01104 liver and spleen .i 4123 to 4333 211 to 1       211/211
(100 %)
1 diff
(99.6 %id)
R87733 liver and spleen .i 4126 to 4313 188 to 1   fully sequenced,   188/188
(100 %)
0 diff
(100 %id)
FN161542 breast carcinoma .i 4132 to 4249 1 to 118       118/118
(100 %)
1 diff
(99.2 %id)
FN119504 breast carcinoma .i 4147 to 4250 1 to 102       102/109
(93 %)
2 diff
(98.2 %id)
DB553841 hypothalamus .i 4170 to 4328 323 to 488     Submitted on the opposite strand 416/488
(85 %)
18 diff
(96.4 %id)
N90219 parathyroid gland, parathyroid tumor .i 4177 to 4339 163 to 1   fully sequenced,   163/163
(100 %)
2 diff
(98.8 %id)
BE698128 uterus_tumor .i 4184 to 4293 1 to 110       110/110
(100 %)
2 diff
(98.2 %id)
DB546038 hippocampus .i 4193 to 4330 33 to 170     Submitted on the opposite strand 138/170
(81 %)
6 diff
(96.5 %id)
FN088037 breast carcinoma .i 4229 to 4318 86 to 1     Submitted on the opposite strand 86/87
(98 %)
4 diff
(95.5 %id)
BG679514 skin, squamous cell carcinoma .j-u 1 to 763 1 to 771   tiling clone,   771/837
(92 %)
17 diff
(98.0 %id)
BX101948 uterus .j-u 254 to 524 1 to 271       271/276
(98 %)
1 diff
(99.7 %id)
AA120891 uterus .j-u 269 to 519 1 to 251     Submitted on the opposite strand 251/251
(100 %)
0 diff
(100 %id)
AA120890 uterus .j-u 284 to 518 237 to 1     Submitted on the opposite strand 237/242
(97 %)
2 diff
(99.2 %id)
AI393888 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j-u 287 to 524 246 to 9       238/246
(96 %)
0 diff
(100 %id)
AA331882 Embryo, 8 weeks .j-u 509 to 737 1 to 230       230/232
(99 %)
4 diff
(98.3 %id)
AA333399 Embryo, 8 weeks .j-u 509 to 727 1 to 222       222/222
(100 %)
7 diff
(96.9 %id)
AW955800   .j-u 510 to 1273 1 to 765   tiling clone,   765/765
(100 %)
16 diff
(98.0 %id)
H65929 liver and spleen .j-u 679 to 1085 1 to 415       415/433
(95 %)
14 diff
(96.8 %id)
DW407965 Liver .j-u 972 to 1409 16 to 452       437/453
(96 %)
5 diff
(98.9 %id)
AA644628 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j-u 979 to 1345 1 to 366       366/366
(100 %)
1 diff
(99.8 %id)
AI870895 anaplastic oligodendroglioma, brain .j-u 1110 to 1621 512 to 1 P55X tiling clone,   512/512
(100 %)
0 diff
(100 %id)
H65842 liver and spleen .j-u 1122 to 1533 420 to 1 Q2V V3M L4P P5G S7A ...     420/421
(99 %)
15 diff
(96.5 %id)
AU117562 whole embryo, mainly head .j-u 1171 to 1959 2 to 790 exact capped   789/789
(100 %)
7 diff
(99.2 %id)
BQ876785 sympathetic trunk .j-u 1249 to 2050 2 to 807       806/899
(89 %)
14 diff
(98.5 %id)
BG253805 adenocarcinoma, cell line, Prostate .j-u 1255 to 2068 1 to 808       808/932
(86 %)
17 diff
(98.2 %id)
CD675878 eye, lens .j-u 1261 to 1877 1 to 617       617/617
(100 %)
0 diff
(100 %id)
BM017170 astrocytoma grade IV, cell line, brain .j-u 1275 to 1881 1 to 605       605/605
(100 %)
3 diff
(99.6 %id)
TI_59387419   .j-u 1275 to 1881 98 to 702       605/605
(100 %)
3 diff
(99.6 %id)
BM310820 Pancreas, Purified pancreatic islet .j-u 1281 to 1773 5 to 497       493/497
(99 %)
6 diff
(98.8 %id)
CK001118 brain/CNS, Bulk tissue from Human Spinal cord .j-u 1281 to 1964 1 to 679       679/687
(98 %)
11 diff
(98.4 %id)
BI822181 pooled brain, lung, testis .j-u 1286 to 2133 1 to 852       852/856
(99 %)
7 diff
(99.2 %id)
TI_57199012   .j-u 1286 to 2133 70 to 921       852/925
(92 %)
7 diff
(99.3 %id)
CN343112 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j-u 1292 to 1723 1 to 431       431/431
(100 %)
1 diff
(99.8 %id)
BG695897 skin .j-u 1300 to 2049 1 to 751       751/751
(100 %)
2 diff
(99.8 %id)
BX362045   .j-u 1318 to 2262 945 to 1       945/948
(99 %)
29 diff
(97.0 %id)
AL516131 brain, neuroblastoma, neuroblastoma cells .j-u 1337 to 2283 951 to 4       948/951
(99 %)
0 diff
(100 %id)
TI_182940333   .j-u 1342 to 2310 1031 to 79   AAA   953/1022
(93 %)
15 diff
(98.6 %id)
BX355845 Placenta Cot 25-normalized .j-u 1377 to 2269 899 to 1       899/899
(100 %)
20 diff
(97.8 %id)
BF761306 colon_est .j-u 1387 to 1916 539 to 11     Submitted on the opposite strand 529/539
(98 %)
0 diff
(100 %id)
BF809359 colon_ins .j-u 1420 to 1563 185 to 42     Submitted on the opposite strand 144/185
(77 %)
0 diff
(100 %id)
CD639890 pooled .j-u 1445 to 2142 1 to 696       696/696
(100 %)
9 diff
(98.8 %id)
BM793724 Ascites, stomach .j-u 1453 to 2092 1 to 640       640/640
(100 %)
0 diff
(100 %id)
TI_149298184   .j-u 1454 to 2296 918 to 78   AAA   841/964
(87 %)
6 diff
(99.4 %id)
CB243083 Human Lung Epithelial cells, lung .j-u 1498 to 2310 829 to 17   tiling clone, AAA   813/825
(98 %)
6 diff
(99.3 %id)
NR_024080.1   .k 1 to 1578 1 to 1578 exact RefSeq, tiling clone, AAA   1578/1578
(100 %)
0 diff
(100 %id)
AU279535   .k 32 to 569 1 to 538 T53I     538/538
(100 %)
2 diff
(99.7 %id)
BJ992018 hepatoblastoma .k 32 to 455 1 to 424 exact     424/424
(100 %)
0 diff
(100 %id)
BP872585 embryonal kidney .k 32 to 614 1 to 583 exact     583/583
(100 %)
4 diff
(99.4 %id)
DA134468 alzheimer cortex .k 33 to 570 2 to 539 exact capped   538/538
(100 %)
0 diff
(100 %id)
DA684852   .k 33 to 591 2 to 560 exact capped   559/559
(100 %)
1 diff
(99.9 %id)
DA711288   .k 33 to 589 2 to 558 T53I capped   557/557
(100 %)
2 diff
(99.7 %id)
DN998435 bone marrow .k 44 to 709 1 to 666 T53I     666/666
(100 %)
6 diff
(99.1 %id)
BQ277518 mixed (pool of 40 RNAs) .k 68 to 801 1 to 739 T53I     739/923
(80 %)
16 diff
(98.3 %id)
TI_151702593   .k 73 to 805 798 to 98 A2R E3D Q4S A5I T6Q ... AAA   643/1162
(55 %)
40 diff
(96.6 %id)
BI545150 brain, hippocampus .k 74 to 749 1 to 676 exact     676/676
(100 %)
4 diff
(99.5 %id)
FN126389 breast carcinoma .k 75 to 155 1 to 81       81/81
(100 %)
2 diff
(97.6 %id)
BG541800 lung .k 75 to 696 1 to 622 exact     622/623
(99 %)
6 diff
(99.1 %id)
BG569962 lung .k 75 to 891 1 to 816 F11L V12C C13V L14W G15V ...     816/816
(100 %)
23 diff
(97.2 %id)
CD703681 normal nasopharynx .k 76 to 177 12 to 116       105/116
(90 %)
7 diff
(94.0 %id)
FN124419 breast carcinoma .k 76 to 175 103 to 3     Submitted on the opposite strand 101/104
(97 %)
3 diff
(97.2 %id)
BU534130 mixed (pool of 40 RNAs) .k 76 to 791 1 to 729 exact     729/996
(73 %)
16 diff
(98.4 %id)
BU959358 mixed (pool of 40 RNAs) .k 76 to 704 1 to 630 exact     630/827
(76 %)
3 diff
(99.7 %id)
DW464695 Liver .k 78 to 164 13 to 101       89/101
(88 %)
8 diff
(92.1 %id)
TI_44001196   .k 79 to 749 90 to 760 exact     671/760
(88 %)
6 diff
(99.3 %id)
BU533391 mixed (pool of 40 RNAs) .k 84 to 786 1 to 709 T53I AAA   709/738
(96 %)
18 diff
(97.6 %id)
BG944289 blood .k 86 to 489 1 to 404 exact     404/404
(100 %)
1 diff
(99.8 %id)
BI767615 pooled lung and spleen .k 89 to 922 1 to 827 F11L V12C C13V L14W G15V ...     827/827
(100 %)
12 diff
(98.6 %id)
TI_57183844   .k 89 to 922 34 to 860 F11L V12C C13V L14W G15V ...     827/860
(96 %)
14 diff
(98.4 %id)
BI048032 stomach .k 95 to 204 1 to 114       114/114
(100 %)
5 diff
(95.7 %id)
TI_57183098   .k 96 to 850 67 to 818 T53I     752/818
(91 %)
12 diff
(98.6 %id)
EL735573 mixed .k 97 to 308 1 to 212       212/395
(53 %)
1 diff
(99.8 %id)
Y16846 placenta .k 97 to 673 1 to 577 T53I Q68K E69S L70C     577/577
(100 %)
3 diff
(99.5 %id)
CN344030 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 98 to 815 1 to 718       718/718
(100 %)
1 diff
(99.9 %id)
FN066164 breast carcinoma .k 99 to 177 1 to 79       79/79
(100 %)
1 diff
(98.8 %id)
BG035989 adenocarcinoma, cell line, Liver .k 99 to 807 1 to 709   AAA   709/709
(100 %)
5 diff
(99.3 %id)
BI771554 pooled lung and spleen .k 99 to 850 1 to 749       749/749
(100 %)
6 diff
(99.2 %id)
BM477153 lymph, lymphoma, cell line .k 100 to 1054 1 to 960       960/1111
(86 %)
24 diff
(97.9 %id)
BG012732 placenta_normal .k 107 to 472 366 to 1       366/368
(99 %)
7 diff
(98.1 %id)
BF001721 colon, colon tumor, RER+ .k 108 to 805 697 to 1       697/699
(99 %)
2 diff
(99.8 %id)
BG011178 placenta_normal .k 109 to 472 364 to 1       364/379
(96 %)
3 diff
(99.3 %id)
AA829649 germinal center B cell .k 114 to 804 664 to 1       609/664
(91 %)
39 diff
(94.2 %id)
BF809367 colon_ins .k 119 to 483 378 to 15     Submitted on the opposite strand 364/378
(96 %)
1 diff
(99.8 %id)
AA205090   .k 138 to 212 1 to 74       74/74
(100 %)
2 diff
(97.3 %id)
BF809364 colon_ins .k 147 to 472 43 to 368       326/368
(88 %)
8 diff
(97.9 %id)
BQ002404 Chondrosarcoma, Left Pelvis .k 222 to 803 598 to 17   AAA   582/582
(100 %)
0 diff
(100 %id)
AW471086 colon, moderately-differentiated adenocarcinoma .k 243 to 801 559 to 1       559/574
(97 %)
8 diff
(98.7 %id)
FN167730 breast carcinoma .k 320 to 401 82 to 1     Submitted on the opposite strand 82/97
(84 %)
1 diff
(99.0 %id)
BG012724 placenta_normal .k 324 to 472 149 to 1       149/156
(95 %)
0 diff
(100 %id)
N47624 multiple sclerosis lesions .k 341 to 829 1 to 495       495/495
(100 %)
14 diff
(97.2 %id)
FN151142 breast carcinoma .k 346 to 444 1 to 96       96/96
(100 %)
8 diff
(91.7 %id)
AA975575 2 pooled tumors (clear cell type), Kidney .k 346 to 804 463 to 5       459/463
(99 %)
2 diff
(99.6 %id)
FN147830 breast carcinoma .k 355 to 434 78 to 1     Submitted on the opposite strand 78/92
(84 %)
2 diff
(97.9 %id)
AI276930 placenta .k 355 to 806 458 to 7       452/475
(95 %)
4 diff
(99.2 %id)
AI302383 2 pooled tumors (clear cell type), Kidney .k 355 to 804 451 to 3       449/484
(92 %)
5 diff
(99.0 %id)
AW392256 stomach .k 356 to 688 41 to 373       333/375
(88 %)
12 diff
(96.8 %id)
AI052614 liver and spleen .k 361 to 806 450 to 5       446/450
(99 %)
1 diff
(99.8 %id)
AI301354 2 pooled tumors (clear cell type), Kidney .k 362 to 802 451 to 9       443/451
(98 %)
15 diff
(96.7 %id)
BX452563 adult brain, brain .k 371 to 1221 1 to 850       850/974
(87 %)
26 diff
(97.4 %id)
BX452564 adult brain, brain .k 371 to 1290 1 to 932       932/932
(100 %)
32 diff
(96.6 %id)
CB144180 Liver .k 374 to 829 1 to 456       456/456
(100 %)
0 diff
(100 %id)
AI913924 colon .k 382 to 802 424 to 6       419/424
(98 %)
2 diff
(99.6 %id)
AI953493 Kidney .k 399 to 801 418 to 14   AAA   405/405
(100 %)
8 diff
(98.1 %id)
BE221706 Kidney .k 399 to 801 416 to 14   AAA   403/403
(100 %)
0 diff
(100 %id)
BE221774.
matches multiple genes
Kidney .k 401 to 767 417 to 51   tiling clone, also hits gene cheysubu 367/419
(87 %)
1 diff
(99.8 %id)
AA909255 pooled .k 409 to 802 393 to 1       393/397
(98 %)
18 diff
(95.5 %id)
BQ083103 Ascites, stomach .k 409 to 841 1 to 433       433/433
(100 %)
1 diff
(99.8 %id)
BE929632 placenta_normal .k 412 to 794 1 to 381       381/384
(99 %)
12 diff
(96.9 %id)
CN343126 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 417 to 923 21 to 527       507/527
(96 %)
6 diff
(98.9 %id)
AA635044 lung, lung carcinoma .k 419 to 809 1 to 391       391/395
(98 %)
5 diff
(98.8 %id)
AA861354   .k 420 to 804 391 to 6       386/391
(98 %)
1 diff
(99.8 %id)
AI192039   .k 421 to 804 387 to 3       385/459
(83 %)
12 diff
(97.4 %id)
BE206327 adenocarcinoma cell line, ovary .k 421 to 806 387 to 3       385/387
(99 %)
17 diff
(95.7 %id)
BM765513 stomach .k 423 to 1062 1 to 641       641/641
(100 %)
1 diff
(99.9 %id)
BM770461 stomach .k 423 to 933 1 to 511       511/511
(100 %)
0 diff
(100 %id)
CN343128 embryonic stem cells, DMSO-treated H9 cellline .k 431 to 536 1 to 107       107/107
(100 %)
1 diff
(99.1 %id)
BQ421255 large cell carcinoma, lung .k 432 to 1290 1 to 861       861/861
(100 %)
6 diff
(99.4 %id)
BF095487 uterus_tumor .k 442 to 772 331 to 1       331/378
(87 %)
7 diff
(98.2 %id)
CN343117 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 443 to 661 1 to 219       219/219
(100 %)
0 diff
(100 %id)
CB109799 Liver .k 445 to 805 1 to 361   AAA   361/361
(100 %)
1 diff
(99.8 %id)
BQ355868 head_neck .k 446 to 761 10 to 324       315/335
(94 %)
10 diff
(97.1 %id)
CB130184 Liver .k 446 to 990 26 to 570       545/545
(100 %)
2 diff
(99.7 %id)
BQ355877 head_neck .k 462 to 761 22 to 319       298/330
(90 %)
10 diff
(97.0 %id)
CD673215 eye, Iris .k 465 to 973 1 to 509       509/509
(100 %)
0 diff
(100 %id)
BQ361710 ovary .k 474 to 617 1 to 141       141/143
(98 %)
10 diff
(93.1 %id)
AL044282 testis .k 478 to 864 1 to 386       386/389
(99 %)
3 diff
(99.3 %id)
N44808 melanocyte .k 479 to 792 1 to 313       313/313
(100 %)
1 diff
(99.7 %id)
BU177090 melanotic melanoma, skin .k 486 to 1325 1 to 850       850/883
(96 %)
24 diff
(97.3 %id)
H28515 breast .k 508 to 864 1 to 357       357/360
(99 %)
2 diff
(99.5 %id)
AA481233 germinal center B cell .k 512 to 1007 1 to 493       493/494
(99 %)
9 diff
(98.2 %id)
EC471109 Prostate .k 521 to 616 1 to 97       97/97
(100 %)
2 diff
(98.0 %id)
N42406 melanocyte .k 526 to 771 1 to 245       245/245
(100 %)
1 diff
(99.6 %id)
AA652635 normal prostate, Prostate .k 536 to 800 265 to 1       265/265
(100 %)
25 diff
(90.6 %id)
DW409367 Liver .k 537 to 808 17 to 288   AAA   272/288
(94 %)
6 diff
(98.0 %id)
AA467801   .k 537 to 736 1 to 197       197/197
(100 %)
8 diff
(96.0 %id)
AA467733   .k 543 to 804 263 to 2       262/270
(97 %)
0 diff
(100 %id)
AI310978 2 pooled tumors (clear cell type), Kidney .k 549 to 804 261 to 6       256/261
(98 %)
0 diff
(100 %id)
BF796146 lymph, lymphoma, cell line .k 558 to 803 1 to 245   AAA   245/245
(100 %)
1 diff
(99.6 %id)
AI653919 serous papillary carcinoma, high grade, 2pooled tumors, uterus .k 559 to 801 255 to 13   AAA   243/243
(100 %)
1 diff
(99.6 %id)
DW449748 Liver .k 568 to 753 17 to 202       186/202
(92 %)
6 diff
(97.1 %id)
CK825259 Pancreas, Purified pancreatic islet .k 587 to 736 1 to 146     Submitted on the opposite strand 146/146
(100 %)
6 diff
(95.9 %id)
AA528598 Kidney .k 615 to 806 7 to 197       191/209
(91 %)
3 diff
(98.6 %id)
EC541508 Prostate .k 690 to 796 117 to 11       107/117
(91 %)
0 diff
(100 %id)
BX436001 T cells (Jurkat cell line) .k 753 to 1552 820 to 10       811/915
(88 %)
0 diff
(100 %id)
TI_149302827   .k 766 to 1578 867 to 62   AAA   806/948
(85 %)
13 diff
(98.7 %id)
BU852495 testis .k 770 to 1537 1 to 777       777/778
(99 %)
15 diff
(98.1 %id)
BE618829 eye, retinoblastoma .k 776 to 1560 797 to 6       792/884
(89 %)
0 diff
(100 %id)
AA115331 uterus .k 777 to 1210 1 to 424   fully sequenced,   424/424
(100 %)
6 diff
(98.6 %id)
FN080570 breast carcinoma .k 780 to 858 1 to 80       80/83
(96 %)
7 diff
(91.6 %id)
AA233822 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k 780 to 1320 1 to 526       526/526
(100 %)
11 diff
(98.0 %id)
TI_149315004   .k 781 to 1558 857 to 87   AAA   771/979
(78 %)
21 diff
(97.9 %id)
AA886872 2 pooled tumors (clear cell type), Kidney .k 787 to 1578 791 to 13   AAA   779/779
(100 %)
35 diff
(95.6 %id)
DA444632 tongue, tumor tissue .k 794 to 1363 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BE881000 large cell carcinoma, undifferentiated, lung .k 796 to 1473 1 to 678       678/678
(100 %)
2 diff
(99.8 %id)
FN123423 breast carcinoma .k 798 to 897 1 to 102       102/103
(99 %)
4 diff
(96.2 %id)
N57479 multiple sclerosis lesions .k 1104 to 1581 483 to 5       479/484
(98 %)
0 diff
(100 %id)
N33430 melanocyte .k 1149 to 1576 432 to 3       430/432
(99 %)
0 diff
(100 %id)
AA115242 uterus .k 1180 to 1578 394 to 1   fully sequenced,   394/394
(100 %)
1 diff
(99.8 %id)
AA205145   .k 1188 to 1577 392 to 1       392/395
(99 %)
3 diff
(99.3 %id)
N35504 melanocyte .k 1240 to 1571 332 to 1       332/332
(100 %)
0 diff
(100 %id)
DA388244 thalamus .l-u 1 to 590 2 to 591 exact tiling clone, capped   590/590
(100 %)
0 diff
(100 %id)
DB239418 trachea .m-u 1 to 585 2 to 586 exact tiling clone, capped   585/585
(100 %)
0 diff
(100 %id)
DB022818 testis .n 1 to 545 2 to 546 Q43R tiling clone, capped   545/545
(100 %)
2 diff
(99.7 %id)
BX108392 Kidney .o-u 1 to 488 1 to 490   tiling clone,   490/490
(100 %)
5 diff
(99.0 %id)
AA594781 breast .o-u 39 to 502 464 to 1 exact tiling clone,   464/464
(100 %)
1 diff
(99.8 %id)
FN053186 breast carcinoma .o-u 149 to 249 101 to 1     Submitted on the opposite strand 101/102
(99 %)
0 diff
(100 %id)
AA887438 Kidney .o-u 269 to 502 234 to 1 exact     234/234
(100 %)
1 diff
(99.6 %id)
BU598863 mixed (pool of 40 RNAs) .p 1 to 413 2 to 416 E2Q H41P T42H A43S H44P ... tiling clone,   416/865
(48 %)
13 diff
(98.5 %id)
FN166624 breast carcinoma Gene ACP1, variant not shown         Submitted on the opposite strand    
88 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l-u, .m-u, .n, .o-u, .p Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI